CYP3A4 Anticorps
(Cytochrome P450, Family 3, Subfamily A, Polypeptide 4 (CYP3A4))
Choisissez l’un des 122 anticorps CYP3A4 de notre liste de produits basés sur 8 publications et 69 images de validation.
Découvrez des anticorps CYP3A4 fiables issus d’une large sélection de fabricants renommés. Notre portefeuille permet une détection précise de CYP3A4 dans plusieurs espèces, y compris Human, Mouse, Rat, Cow, Dog, Guinea Pig, Pig, Rabbit, Sheep, Goat, Horse, Monkey, et prend en charge diverses applications de recherche telles que WB, IHC, ELISA, FACS, IF.
Trouvez rapidement l’anticorps adapté grâce à nos outils de recherche, de filtrage et de comparaison. Chaque page produit fournit des données de validation détaillées, des références bibliographiques et des retours d’utilisateurs. Contrairement aux ressources dédiées uniquement à la comparaison, vous pouvez acheter directement les anticorps sur notre site. Choisissez parmi des anticorps polyclonaux, monoclonaux ou recombinants CYP3A4, issus de différents hôtes tels que Rabbit, Mouse, Goat. Parcourez nos produits ci-dessous et commandez directement pour soutenir vos recherches en toute confiance.
Les noms alternatifs de CYP3A4 sont CYP3A4, CYP3A43, PTRG_01782, PTRG_06060, cyp3a4.
| Catalog no. | Produit | Reactivité | Hôte / Clonalité | Application | Prix et délai de livraison |
|---|---|---|---|---|---|
| CYP3A4 anticorps (Middle Region) (Biotin) | Humain | Lapin Polyclonal |
|
742,50 €
Voir le prix
|
|
| CYP3A4 anticorps (Middle Region) | Humain | Lapin Polyclonal |
|
522,50 €
Voir le prix
|
|
| CYP3A4 anticorps (Middle Region) | Humain | Lapin Polyclonal |
|
522,50 €
Voir le prix
|
|
| CYP3A4 anticorps (Middle Region) (HRP) | Humain | Lapin Polyclonal |
|
742,50 €
Voir le prix
|
|
| CYP3A4 anticorps (AA 44-267) | Humain | Lapin Polyclonal |
|
522,50 €
Voir le prix
|
|
| CYP3A4 anticorps (AA 44-267) (APC) | Humain | Lapin Polyclonal |
|
1.017,50 €
Voir le prix
|
|
| CYP3A4 anticorps (Middle Region) (APC) | Humain | Lapin Polyclonal |
|
1.017,50 €
Voir le prix
|
|
| CYP3A4 anticorps (Middle Region) (APC) | Humain | Lapin Polyclonal |
|
1.017,50 €
Voir le prix
|
|
| CYP3A4 anticorps (Middle Region) (FITC) | Humain | Lapin Polyclonal |
|
742,50 €
Voir le prix
|
|
| CYP3A4 anticorps (AA 44-267) (FITC) | Humain | Lapin Polyclonal |
|
742,50 €
Voir le prix
|
|
| CYP3A4 anticorps (Middle Region) (FITC) | Humain | Lapin Polyclonal |
|
742,50 €
Voir le prix
|
|
| CYP3A4 anticorps (Middle Region) (Fluoro488) | Humain | Lapin Polyclonal |
|
742,50 €
Voir le prix
|
|
| CYP3A4 anticorps (Middle Region) (Fluoro488) | Humain | Lapin Polyclonal |
|
742,50 €
Voir le prix
|
|
| CYP3A4 anticorps (AA 44-267) (Fluoro488) | Humain | Lapin Polyclonal |
|
742,50 €
Voir le prix
|
|
| CYP3A4 anticorps (N-Term) | Humain | Lapin Polyclonal |
|
534,11 €
Voir le prix
|
|
| CYP3A4 anticorps (AA 228-255) | Humain | Lapin Polyclonal |
|
631,13 €
Voir le prix
|
|
| CYP3A4 anticorps (Middle Region) (PE) | Humain | Lapin Polyclonal |
|
1.017,50 €
Voir le prix
|
|
| CYP3A4 anticorps (Middle Region) (PE) | Humain | Lapin Polyclonal |
|
1.017,50 €
Voir le prix
|
|
| CYP3A4 anticorps (AA 44-267) (PE) | Humain | Lapin Polyclonal |
|
1.017,50 €
Voir le prix
|
|
| CYP3A4 anticorps (Middle Region) (Fluoro647) | Humain | Lapin Polyclonal |
|
852,50 €
Voir le prix
|
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IHC (Immunohistochemistry: Application indiquée)
- ELISA (ELISA: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Biotin
- Isotype
- IgG
- Epitope
- Middle Region
Primary Antibody
- WB (Western Blotting: Application indiquée)
- FACS (Flow Cytometry: Application indiquée)
- Classe de qualité
- Carrier-free
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- unconjugated
- Isotype
- IgG
- Epitope
- Middle Region
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IHC (Immunohistochemistry: Application indiquée)
- Classe de qualité
- Carrier-free
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- unconjugated
- Isotype
- IgG
- Epitope
- Middle Region
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IHC (Immunohistochemistry: Application indiquée)
- ELISA (ELISA: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- HRP
- Isotype
- IgG
- Epitope
- Middle Region
Primary Antibody
- WB (Western Blotting: Application indiquée)
- ELISA (ELISA: Application indiquée)
- FACS (Flow Cytometry: Application indiquée)
- Classe de qualité
- Carrier-free
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- unconjugated
- Isotype
- IgG
- Epitope
- AA 44-267
Primary Antibody
- WB (Western Blotting: Application indiquée)
- ELISA (ELISA: Application indiquée)
- FACS (Flow Cytometry: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- APC
- Isotype
- IgG
- Epitope
- AA 44-267
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IHC (Immunohistochemistry: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- APC
- Isotype
- IgG
- Epitope
- Middle Region
Primary Antibody
- WB (Western Blotting: Application indiquée)
- FACS (Flow Cytometry: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- APC
- Isotype
- IgG
- Epitope
- Middle Region
Primary Antibody
- WB (Western Blotting: Application indiquée)
- FACS (Flow Cytometry: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- FITC
- Isotype
- IgG
- Epitope
- Middle Region
Primary Antibody
- WB (Western Blotting: Application indiquée)
- ELISA (ELISA: Application indiquée)
- FACS (Flow Cytometry: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- FITC
- Isotype
- IgG
- Epitope
- AA 44-267
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IHC (Immunohistochemistry: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- FITC
- Isotype
- IgG
- Epitope
- Middle Region
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IHC (Immunohistochemistry: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Fluoro488
- Isotype
- IgG
- Epitope
- Middle Region
Primary Antibody
- WB (Western Blotting: Application indiquée)
- FACS (Flow Cytometry: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Fluoro488
- Isotype
- IgG
- Epitope
- Middle Region
Primary Antibody
- WB (Western Blotting: Application indiquée)
- ELISA (ELISA: Application indiquée)
- FACS (Flow Cytometry: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Fluoro488
- Isotype
- IgG
- Epitope
- AA 44-267
Primary Antibody
- WB (Western Blotting: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- unconjugated
- Epitope
- N-Term
Primary Antibody
- WB (Western Blotting: Application indiquée)
- FACS (Flow Cytometry: Application indiquée)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- unconjugated
- Isotype
- Ig Fraction
- Epitope
- AA 228-255
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IHC (Immunohistochemistry: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- PE
- Isotype
- IgG
- Epitope
- Middle Region
Primary Antibody
- WB (Western Blotting: Application indiquée)
- FACS (Flow Cytometry: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- PE
- Isotype
- IgG
- Epitope
- Middle Region
Primary Antibody
- WB (Western Blotting: Application indiquée)
- ELISA (ELISA: Application indiquée)
- FACS (Flow Cytometry: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- PE
- Isotype
- IgG
- Epitope
- AA 44-267
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IHC (Immunohistochemistry: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Fluoro647
- Isotype
- IgG
- Epitope
- Middle Region
Dernières publications pour nos CYP3A4 Anticorps
: "PAMAM dendrimer grafted cellulose paper scaffolds as a novel in vitro 3D liver model for drug screening applications." dans: Colloids and surfaces. B, Biointerfaces, Vol. 172, pp. 346-354, (2019) (PubMed).
: "Sesquiterpenes Are Agonists of the Pregnane X Receptor but Do Not Induce the Expression of Phase I Drug-Metabolizing Enzymes in the Human Liver." dans: International journal of molecular sciences, Vol. 20, Issue 18, (2019) (PubMed).
: "Comparative pharmacokinetics and safety assessment of transdermal berberine and dihydroberberine." dans: PLoS ONE, Vol. 13, Issue 3, pp. e0194979, (2018) (PubMed).
: "Oroxylin A activates PKM1/HNF4 alpha to induce hepatoma differentiation and block cancer progression." dans: Cell death & disease, Vol. 8, Issue 7, pp. e2944, (2018) (PubMed).
: "Functional expression and comparative characterization of four feline P450 cytochromes using fluorescent substrates." dans: Xenobiotica; the fate of foreign compounds in biological systems, Vol. 47, Issue 11, pp. 951-961, (2017) (PubMed).
: "Ascorbic acid reverses the prolonged anesthetic action of pentobarbital in Akr1a-knockout mice." dans: Life sciences, Vol. 95, Issue 1, pp. 1-8, (2014) (PubMed).
: "Dermal xenobiotic metabolism: a comparison between native human skin, four in vitro skin test systems and a liver system." dans: Skin pharmacology and physiology, Vol. 27, Issue 5, pp. 263-75, (2014) (PubMed).
: "Identification and characterization of a defective CYP3A4 genotype in a kidney transplant patient with severely diminished tacrolimus clearance." dans: Clinical pharmacology and therapeutics, Vol. 95, Issue 4, pp. 416-22, (2014) (PubMed).
: "Extensive protein interactions involving cytochrome P450 3A4: a possible contributor to the formation of a metabolosome." dans: Pharmacology research & perspectives, Vol. 2, Issue 5, pp. e00053, (2014) (PubMed).
: "Phase I and II metabolism and MRP2-mediated export of bosentan in a MDCKII-OATP1B1-CYP3A4-UGT1A1-MRP2 quadruple-transfected cell line." dans: British journal of pharmacology, Vol. 169, Issue 1, pp. 21-33, (2013) (PubMed).
: "Sesquiterpenes Are Agonists of the Pregnane X Receptor but Do Not Induce the Expression of Phase I Drug-Metabolizing Enzymes in the Human Liver." dans: International journal of molecular sciences, Vol. 20, Issue 18, (2019) (PubMed).
: "Comparative pharmacokinetics and safety assessment of transdermal berberine and dihydroberberine." dans: PLoS ONE, Vol. 13, Issue 3, pp. e0194979, (2018) (PubMed).
: "Oroxylin A activates PKM1/HNF4 alpha to induce hepatoma differentiation and block cancer progression." dans: Cell death & disease, Vol. 8, Issue 7, pp. e2944, (2018) (PubMed).
: "Functional expression and comparative characterization of four feline P450 cytochromes using fluorescent substrates." dans: Xenobiotica; the fate of foreign compounds in biological systems, Vol. 47, Issue 11, pp. 951-961, (2017) (PubMed).
: "Ascorbic acid reverses the prolonged anesthetic action of pentobarbital in Akr1a-knockout mice." dans: Life sciences, Vol. 95, Issue 1, pp. 1-8, (2014) (PubMed).
: "Dermal xenobiotic metabolism: a comparison between native human skin, four in vitro skin test systems and a liver system." dans: Skin pharmacology and physiology, Vol. 27, Issue 5, pp. 263-75, (2014) (PubMed).
: "Identification and characterization of a defective CYP3A4 genotype in a kidney transplant patient with severely diminished tacrolimus clearance." dans: Clinical pharmacology and therapeutics, Vol. 95, Issue 4, pp. 416-22, (2014) (PubMed).
: "Extensive protein interactions involving cytochrome P450 3A4: a possible contributor to the formation of a metabolosome." dans: Pharmacology research & perspectives, Vol. 2, Issue 5, pp. e00053, (2014) (PubMed).
: "Phase I and II metabolism and MRP2-mediated export of bosentan in a MDCKII-OATP1B1-CYP3A4-UGT1A1-MRP2 quadruple-transfected cell line." dans: British journal of pharmacology, Vol. 169, Issue 1, pp. 21-33, (2013) (PubMed).
Pseudonymes pour CYP3A4 Anticorps
cytochrome P450 family 3 subfamily A member 4 (CYP3A4) Anticorpscytochrome P450 family 3 subfamily A member 43 (CYP3A43) Anticorps
cytochrome P450 3A4 (PTRG_01782) Anticorps
cytochrome P450 3A4 (PTRG_06060) Anticorps
cytochrome P450 family 3 subfamily A member 4 (cyp3a4) Anticorps
cytochrome P450, subfamily IIIA, polypeptide 4 (CYP3A4) Anticorps
cytochrome P450, subfamily IIIA (niphedipine oxidase), polypeptide 4 (CYP3A4) Anticorps
cytochrome P450, family 3, subfamily A, polypeptide 4 (CYP3A4) Anticorps
CP33 Anticorps
CP34 Anticorps
CYP3A Anticorps
CYP3A3 Anticorps
CYP3A4 Anticorps
CYP3A12 Anticorps
CYP3A21 Anticorps
CYP3A80 Anticorps
CYPIIIA3 Anticorps
CYPIIIA4 Anticorps
CYPIIIA21 Anticorps
HLP Anticorps
MGC108372 Anticorps
NF-25 Anticorps
P450C3 Anticorps
P450PCN1 Anticorps
Avez-vous cherché autre chose?
- CYP39A1 Anticorps
- CYP2W1 Anticorps
- CYP2U1 Anticorps
- CYP2S1 Anticorps
- CYP2R1 Anticorps
- CYP2J2 Anticorps
- CYP2F1 Anticorps
- CYP2E1 Anticorps
- CYP2D6 Anticorps
- Cyp2d5 Anticorps
- CYP2C9 Anticorps
- CYP2C8 Anticorps
- CYP2C19 Anticorps
- CYP2C18 Anticorps
- CYP2B6 Anticorps
- CYP2B4 Anticorps
- CYP2A7 Anticorps
- CYP2A6 Anticorps
- CYP2A13 Anticorps
- CYP27C1 Anticorps
- CYP3A5 Anticorps
- CYP3A7 Anticorps
- CYP46A1 Anticorps
- CYP4A11 Anticorps
- CYP4A22 Anticorps
- CYP4B1 Anticorps
- CYP4F11 Anticorps
- CYP4F12 Anticorps
- CYP4F2 Anticorps
- CYP4F22 Anticorps
- CYP4F3 Anticorps
- CYP4F8 Anticorps
- CYP4V2 Anticorps
- CYP4X1 Anticorps
- CYP4Z1 Anticorps
- CYP51A1 Anticorps
- CYP7A1 Anticorps
- CYP7B1 Anticorps
- CYP8B1 Anticorps
- CYR61 Anticorps
Vous êtes ici:
